Cunningham, D., Wong, R. P. W., D'Haens, G., Douillard, J., Robertson, J., Stone, A. M., & Van Cutsem, E. (2013). Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer. Nature Publishing Group.
Citación estilo ChicagoCunningham, D., R P W. Wong, G. D'Haens, J-Y Douillard, J. Robertson, A M. Stone, y E. Van Cutsem. Cediranib With MFOLFOX6 Vs Bevacizumab With MFOLFOX6 in Previously Treated Metastatic Colorectal Cancer. Nature Publishing Group, 2013.
Cita MLACunningham, D., et al. Cediranib With MFOLFOX6 Vs Bevacizumab With MFOLFOX6 in Previously Treated Metastatic Colorectal Cancer. Nature Publishing Group, 2013.
Precaución: Estas citas no son 100% exactas.